Cargando…
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Adrenocortical carcinoma (ACC) has a poor prognosis with significant unmet clinical need due to late diagnosis, high rates of recurrence/metastasis and poor response to conventional treatment. Replacing tumor suppressor microRNAs (miRNAs) offer a novel therapy, however systemic delivery remains chal...
Autores principales: | Glover, Anthony R., Zhao, Jing Ting, Gill, Anthony J., Weiss, Jocelyn, Mugridge, Nancy, Kim, Edward, Feeney, Alex L., Ip, Julian C., Reid, Glen, Clarke, Stephen, Soon, Patsy S.H., Robinson, Bruce G., Brahmbhatt, Himanshu, MacDiarmid, Jennifer A., Sidhu, Stan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742203/ https://www.ncbi.nlm.nih.gov/pubmed/26452132 |
Ejemplares similares
-
Translational applications of microRNAs in cancer, and therapeutic implications
por: Kwok, Grace T., et al.
Publicado: (2017) -
Current management options for recurrent adrenocortical carcinoma
por: Glover, Anthony R, et al.
Publicado: (2013) -
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma
por: Williams, Marissa, et al.
Publicado: (2015) -
Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
por: Brahmbhatt, Himanshu, et al.
Publicado: (2021) -
Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
por: Gao, Steven Y., et al.
Publicado: (2023)